Inhibiting miR-466b-5p Attenuates Neonatal White Matter Injury by Targeting Lpar1

Area of Science:

• Neuroscience
• Molecular Biology
• Developmental Biology

Background:

• White matter injury (WMI) is a significant cause of neurological deficits in neonates.
• Oligodendrocyte precursor cells (OPCs) are crucial for myelination, and their dysfunction contributes to WMI pathogenesis.
• The role of microRNA-466b-5p (miR-466b-5p) in neonatal WMI remains largely unexplored.

Purpose of the Study:

• To investigate the function of miR-466b-5p in neonatal WMI.
• To elucidate the underlying molecular mechanisms involving miR-466b-5p in WMI pathogenesis.

Main Methods:

• Establishment of a neonatal WMI rat model using hypoxia-ischemia.
• Bioinformatic analysis to predict miR-466b-5p targets, followed by RT-PCR validation.
• Intracerebroventricular administration of miR-466b-5p antagomir to inhibit its function.
• Assessment of OPC differentiation, apoptosis, proliferation, myelination, and behavioral performance (Morris water maze test).
• Analysis of Sox10 expression and proteolipid protein (PLP) trafficking.

Main Results:

• Inhibition of miR-466b-5p increased Edg2 protein levels, enhanced OPC differentiation, and improved myelinated axon formation.
• miR-466b-5p inhibition led to improved behavioral performance in rats post-WMI.
• OPC proliferation and apoptosis were not significantly affected by miR-466b-5p inhibition.
• miR-466b-5p inhibition promoted Sox10 expression and attenuated PLP trafficking.

Conclusions:

• miR-466b-5p plays a regulatory role in neonatal WMI pathogenesis.
• The effects of miR-466b-5p inhibition are partly mediated through the Lpar1/Edg2/Sox10 and Lpar1/Edg2/PLP signaling pathways.
• Targeting miR-466b-5p represents a potential therapeutic strategy for neonatal WMI.